174 related articles for article (PubMed ID: 34214753)
1. Design, synthesis, in vitro and in silico studies of some novel thiazole-dihydrofuran derivatives as aromatase inhibitors.
Osmaniye D; Görgülü Ş; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
Bioorg Chem; 2021 Sep; 114():105123. PubMed ID: 34214753
[TBL] [Abstract][Full Text] [Related]
2. Pyridine-substituted thiazolylphenol derivatives: Synthesis, modeling studies, aromatase inhibition, and antiproliferative activity evaluation.
Ertas M; Sahin Z; Berk B; Yurttas L; Biltekin SN; Demirayak S
Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700272. PubMed ID: 29522642
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, investigation of biological effects and in silico studies of new benzimidazole derivatives as aromatase inhibitors.
Sağlık BN; Şen AM; Evren AE; Çevik UA; Osmaniye D; Kaya Çavuşoğlu B; Levent S; Karaduman AB; Özkay Y; Kaplancıklı ZA
Z Naturforsch C J Biosci; 2020 Sep; 75(9-10):353-362. PubMed ID: 32681791
[TBL] [Abstract][Full Text] [Related]
4. 2-Anilinopyrimidine derivatives: Design, synthesis, in vitro anti-proliferative activity, EGFR and ARO inhibitory activity, cell cycle analysis and molecular docking study.
AboulWafa OM; Daabees HMG; Badawi WA
Bioorg Chem; 2020 Jun; 99():103798. PubMed ID: 32247112
[TBL] [Abstract][Full Text] [Related]
5. A New Series of Antileukemic Agents: Design, Synthesis, In Vitro and In Silico Evaluation of Thiazole-Based ABL1 Kinase Inhibitors.
Zeytün E; Altıntop MD; Sever B; Özdemir A; Ellakwa DE; Ocak Z; Ciftci HI; Otsuka M; Fujita M; Radwan MO
Anticancer Agents Med Chem; 2021; 21(9):1099-1109. PubMed ID: 32838725
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, molecular modeling, DFT, ADME and biological evaluation studies of some new 1,3,4-oxadiazole linked benzimidazoles as anticancer agents and aromatase inhibitors.
Acar Çevik U; Celik I; Işık A; Ahmad I; Patel H; Özkay Y; Kaplancıklı ZA
J Biomol Struct Dyn; 2023 Mar; 41(5):1944-1958. PubMed ID: 35037830
[TBL] [Abstract][Full Text] [Related]
7. Analogue based drug design, synthesis, molecular docking and anticancer evaluation of novel chromene sulfonamide hybrids as aromatase inhibitors and apoptosis enhancers.
Ghorab MM; Alsaid MS; Al-Ansary GH; Abdel-Latif GA; Abou El Ella DA
Eur J Med Chem; 2016 Nov; 124():946-958. PubMed ID: 27770735
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and docking study of benzimidazole-triazolothiadiazine hybrids as aromatase inhibitors.
Acar Çevik U; Sağlık BN; Osmaniye D; Levent S; Kaya Çavuşoğlu B; Karaduman AB; Özkay Y; Kaplancıklı ZA
Arch Pharm (Weinheim); 2020 May; 353(5):e2000008. PubMed ID: 32159244
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, and Biological Evaluation of New Azole Derivatives as Potent Aromatase Inhibitors with Potential Effects against Breast Cancer.
Kalalinia F; Jouya M; Komachali AK; Aboutourabzadeh SM; Karimi G; Behravan J; Abnous K; Etemad L; Kamali H; Hadizadeh F
Anticancer Agents Med Chem; 2018; 18(7):1016-1024. PubMed ID: 29336269
[TBL] [Abstract][Full Text] [Related]
11. Thiazole-Based Thiosemicarbazones: Synthesis, Cytotoxicity Evaluation and Molecular Docking Study.
Gomha SM; Abdelhady HA; Hassain DZH; Abdelmonsef AH; El-Naggar M; Elaasser MM; Mahmoud HK
Drug Des Devel Ther; 2021; 15():659-677. PubMed ID: 33633443
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Multifunctional Hybrid Analogs for Stilbenes, Chalcones and Flavanones.
Cagir A; Odaci B; Varol M; Akcok I; Okur O; Koparal AT
Anticancer Agents Med Chem; 2018 Feb; 17(14):1915-1923. PubMed ID: 28554313
[TBL] [Abstract][Full Text] [Related]
13. A new series of thiazole-hydrazone hybrids for Akt-targeted therapy of non-small cell lung cancer.
Orujova T; Ece A; Akalın Çiftçi G; Özdemir A; Altıntop MD
Drug Dev Res; 2023 Apr; 84(2):185-199. PubMed ID: 36469421
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, Aromatase Inhibitory, Antiproliferative and Molecular Modeling Studies of Functionally Diverse D-Ring Pregnenolone Pyrazoles.
Banday AH; Saeed BA; Al-Masoudi NA
Anticancer Agents Med Chem; 2021; 21(13):1671-1679. PubMed ID: 33238853
[TBL] [Abstract][Full Text] [Related]
15. Studies on non-steroidal inhibitors of aromatase enzyme; 4-(aryl/heteroaryl)-2-(pyrimidin-2-yl)thiazole derivatives.
Sahin Z; Ertas M; Berk B; Biltekin SN; Yurttas L; Demirayak S
Bioorg Med Chem; 2018 May; 26(8):1986-1995. PubMed ID: 29525337
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of novel 1,3,4-thiadiazole derivatives as possible anticancer agents.
Çevik UA; Osmaniye D; Levent S; Sağlik BN; Çavuşoğlu BK; Karaduman AB; Özkay Y; Kaplancikli ZA
Acta Pharm; 2020 Dec; 70(4):499-513. PubMed ID: 32412436
[TBL] [Abstract][Full Text] [Related]
17. Design and Pharmacophore Study of Triazole Analogues as Aromatase Inhibitors.
Banjare L
Anticancer Agents Med Chem; 2024; 24(4):288-303. PubMed ID: 37921212
[TBL] [Abstract][Full Text] [Related]
18. Aromatase inhibitors and apoptotic inducers: Design, synthesis, anticancer activity and molecular modeling studies of novel phenothiazine derivatives carrying sulfonamide moiety as hybrid molecules.
Ghorab MM; Alsaid MS; Samir N; Abdel-Latif GA; Soliman AM; Ragab FA; Abou El Ella DA
Eur J Med Chem; 2017 Jul; 134():304-315. PubMed ID: 28427017
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
20. In Silico Molecular Interaction Studies of Chitosan Polymer with Aromatase Inhibitor: Leads to Letrozole Nanoparticles for the Treatment of Breast Cancer.
Mishra K; Verma SK; Ratre P; Banjare L; Jain A; Thareja S; Jain AK
Anticancer Agents Med Chem; 2021; 21(9):1191-1199. PubMed ID: 32842946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
